Retraction Note to : Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: Regulation of MMP 9 by PDEF
| Errataetall: |
RetractionOf: Mol Cancer. 2010 Jun 15;9:148. - PMID 20550708 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
|---|---|
| Enthalten in: |
Molecular cancer - 20(2021), 1 vom: 27. Aug., Seite 109 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Johnson, Thomas R [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 21.06.2022 published: Electronic RetractionOf: Mol Cancer. 2010 Jun 15;9:148. - PMID 20550708 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1186/s12943-021-01402-x |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM329954385 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM329954385 | ||
| 003 | DE-627 | ||
| 005 | 20231225210238.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s12943-021-01402-x |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1099.xml |
| 035 | |a (DE-627)NLM329954385 | ||
| 035 | |a (NLM)34452613 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Johnson, Thomas R |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Retraction Note to |b Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: Regulation of MMP 9 by PDEF |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 21.06.2022 | ||
| 500 | |a published: Electronic | ||
| 500 | |a RetractionOf: Mol Cancer. 2010 Jun 15;9:148. - PMID 20550708 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 650 | 4 | |a Retraction of Publication | |
| 700 | 1 | |a Koul, Sweaty |e verfasserin |4 aut | |
| 700 | 1 | |a Kumar, Binod |e verfasserin |4 aut | |
| 700 | 1 | |a Khandrika, Lakshmipathi |e verfasserin |4 aut | |
| 700 | 1 | |a Venezia, Sarah |e verfasserin |4 aut | |
| 700 | 1 | |a Maroni, Paul D |e verfasserin |4 aut | |
| 700 | 1 | |a Meacham, Randall B |e verfasserin |4 aut | |
| 700 | 1 | |a Koul, Hari K |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Molecular cancer |d 2002 |g 20(2021), 1 vom: 27. Aug., Seite 109 |w (DE-627)NLM120915979 |x 1476-4598 |7 nnns |
| 773 | 1 | 8 | |g volume:20 |g year:2021 |g number:1 |g day:27 |g month:08 |g pages:109 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1186/s12943-021-01402-x |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 20 |j 2021 |e 1 |b 27 |c 08 |h 109 | ||